"Breast Carcinoma In Situ" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition in which abnormal cells have not spread outside the duct, lobule, or nipple to other tissues of the breast. There are 3 types of breast carcinoma in situ: DUCTAL CARCINOMA IN SITU; LOBULAR CARCINOMA IN SITU; and PAGET DISEASE OF THE NIPPLE
| Descriptor ID |
D000071960
|
| MeSH Number(s) |
C04.557.470.200.240.187 C04.588.180.130 C17.800.090.500.130
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Breast Carcinoma In Situ".
Below are MeSH descriptors whose meaning is more specific than "Breast Carcinoma In Situ".
This graph shows the total number of publications written about "Breast Carcinoma In Situ" by people in this website by year, and whether "Breast Carcinoma In Situ" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Breast Carcinoma In Situ" by people in Profiles.
-
Karimi Z, Phillips J, Brook A, Baker G, Guzman Y, Mehta TS. Upgrade Rates of Pure, Radiology-Pathology Concordant Lobular Neoplasia Diagnosed on Breast Core Needle Biopsy: Is Surgical Excision Warranted? Acad Radiol. 2022 07; 29(7):1029-1038.
-
George A, Sturgeon SR, Hankinson SE, Shadyab AH, Wallace RB, Reeves KW. Psychotropic Medication Use and Postmenopausal Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):254-256.